CN102876630B - 一种高效分离和扩增人脐带血间充质干细胞的方法 - Google Patents
一种高效分离和扩增人脐带血间充质干细胞的方法 Download PDFInfo
- Publication number
- CN102876630B CN102876630B CN201210437524.8A CN201210437524A CN102876630B CN 102876630 B CN102876630 B CN 102876630B CN 201210437524 A CN201210437524 A CN 201210437524A CN 102876630 B CN102876630 B CN 102876630B
- Authority
- CN
- China
- Prior art keywords
- stem cells
- mesenchymal stem
- cord blood
- cell
- umbilical cord
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004700 fetal blood Anatomy 0.000 title claims abstract description 58
- 210000002901 mesenchymal stem cell Anatomy 0.000 title claims abstract description 48
- 238000000034 method Methods 0.000 title claims abstract description 16
- 210000004027 cell Anatomy 0.000 claims abstract description 40
- 210000000130 stem cell Anatomy 0.000 claims abstract description 23
- 238000000926 separation method Methods 0.000 claims abstract description 18
- 239000011248 coating agent Substances 0.000 claims abstract description 6
- 238000000576 coating method Methods 0.000 claims abstract description 6
- 239000003102 growth factor Substances 0.000 claims abstract description 3
- 230000003321 amplification Effects 0.000 claims description 17
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 16
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 10
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 10
- 210000001616 monocyte Anatomy 0.000 claims description 10
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 10
- 239000002609 medium Substances 0.000 claims description 9
- 239000006285 cell suspension Substances 0.000 claims description 8
- SYUXAJSOZXEFPP-UHFFFAOYSA-N glutin Natural products COc1c(O)cc2OC(=CC(=O)c2c1O)c3ccccc3OC4OC(CO)C(O)C(O)C4O SYUXAJSOZXEFPP-UHFFFAOYSA-N 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 claims description 7
- 239000008280 blood Substances 0.000 claims description 7
- 238000009640 blood culture Methods 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 6
- 239000001963 growth medium Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 6
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 5
- 239000003146 anticoagulant agent Substances 0.000 claims description 5
- 229940127219 anticoagulant drug Drugs 0.000 claims description 5
- 229960002897 heparin Drugs 0.000 claims description 5
- 229920000669 heparin Polymers 0.000 claims description 5
- 239000004615 ingredient Substances 0.000 claims description 5
- 229920000609 methyl cellulose Polymers 0.000 claims description 5
- 239000001923 methylcellulose Substances 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- 210000004698 lymphocyte Anatomy 0.000 claims description 4
- 239000011159 matrix material Substances 0.000 claims description 4
- 240000001131 Nostoc commune Species 0.000 claims description 3
- 235000013817 Nostoc commune Nutrition 0.000 claims description 3
- 108010019160 Pancreatin Proteins 0.000 claims description 3
- 206010036590 Premature baby Diseases 0.000 claims description 3
- 230000010261 cell growth Effects 0.000 claims description 3
- 210000003754 fetus Anatomy 0.000 claims description 3
- 238000007710 freezing Methods 0.000 claims description 3
- 230000004927 fusion Effects 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229940055695 pancreatin Drugs 0.000 claims description 3
- 102000009618 Transforming Growth Factors Human genes 0.000 claims description 2
- 108010009583 Transforming Growth Factors Proteins 0.000 claims description 2
- 238000000432 density-gradient centrifugation Methods 0.000 claims description 2
- 229940126864 fibroblast growth factor Drugs 0.000 claims description 2
- 238000002659 cell therapy Methods 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 210000005087 mononuclear cell Anatomy 0.000 abstract 1
- 235000004252 protein component Nutrition 0.000 abstract 1
- 238000001179 sorption measurement Methods 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 10
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 102100022464 5'-nucleotidase Human genes 0.000 description 3
- 102100037241 Endoglin Human genes 0.000 description 3
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 3
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 3
- 101000881679 Homo sapiens Endoglin Proteins 0.000 description 3
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 3
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 3
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 description 3
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 3
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 1
- 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102100027286 Fanconi anemia group C protein Human genes 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102100025304 Integrin beta-1 Human genes 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 101710160107 Outer membrane protein A Proteins 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000003995 blood forming stem cell Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
指示剂 | 反应 |
CD34 | - |
CD45 | - |
CD3 | - |
CD73 | + |
CD105 | + |
CD90 | + |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210437524.8A CN102876630B (zh) | 2012-11-05 | 2012-11-05 | 一种高效分离和扩增人脐带血间充质干细胞的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210437524.8A CN102876630B (zh) | 2012-11-05 | 2012-11-05 | 一种高效分离和扩增人脐带血间充质干细胞的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102876630A CN102876630A (zh) | 2013-01-16 |
CN102876630B true CN102876630B (zh) | 2015-02-18 |
Family
ID=47478149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210437524.8A Active CN102876630B (zh) | 2012-11-05 | 2012-11-05 | 一种高效分离和扩增人脐带血间充质干细胞的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102876630B (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103789259A (zh) * | 2014-02-10 | 2014-05-14 | 江苏霖峯细胞技术股份有限公司 | 自血液样品中同时分离间充质干细胞和造血干细胞的方法 |
CN105524877A (zh) * | 2014-09-29 | 2016-04-27 | 四川新生命干细胞科技股份有限公司 | 一种脐带间充质干细胞的分离方法 |
CN104651304A (zh) * | 2015-02-11 | 2015-05-27 | 广州赛莱拉干细胞科技股份有限公司 | 一种马脐血间充质干细胞的培养基及其分离培养方法 |
CN104630144B (zh) * | 2015-02-13 | 2018-02-13 | 中国医科大学 | 一种脐血间充质干细胞的分离及培养方法 |
CN105861432A (zh) * | 2016-05-31 | 2016-08-17 | 安徽惠恩生物科技股份有限公司 | 人源脐带血造血干细胞体外高效扩增方法 |
CN106754713A (zh) * | 2016-11-07 | 2017-05-31 | 江苏苏博生物医学股份有限公司 | 一种脐带血来源的干细胞的制备方法 |
CN106754673A (zh) * | 2016-12-09 | 2017-05-31 | 北京雨泽瑞清生物科技有限公司 | 一种培养基底的修饰方法及间充质干细胞分离扩增方法 |
CN106580851A (zh) * | 2016-12-09 | 2017-04-26 | 北京雨泽瑞清生物科技有限公司 | 一种间充质干细胞提取物、其提取方法和应用 |
CN108410805B (zh) * | 2018-03-28 | 2019-06-14 | 安徽高安生物医学科技有限公司 | 一种人脐带血干细胞的分离培养方法 |
CN113073077B (zh) * | 2021-04-07 | 2023-03-17 | 德泉生物医学技术(深圳)有限公司 | 一种使用封闭式***培养临床级脐带血间充质干细胞的方法 |
CN113322229A (zh) * | 2021-05-26 | 2021-08-31 | 许清霖 | 一种可分化再生的延缓机体衰老的干细胞培养方法 |
CN113456891B (zh) * | 2021-06-16 | 2022-05-17 | 成都微沃科技有限公司 | 一种从细胞层中提取细胞外基质层的方法 |
CN113774019B (zh) * | 2021-08-11 | 2024-02-13 | 东南大学 | 一种脐带血间充质干细胞无血清培养基、培养方法及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1330142A (zh) * | 2001-07-09 | 2002-01-09 | 中国人民解放军军事医学科学院野战输血研究所 | 人骨髓和脐带血间充质干细胞体外分离扩增和向神经细胞定向诱导的方法 |
CN1878860A (zh) * | 2003-11-11 | 2006-12-13 | 韩薰 | 分离和培养来自脐带血的间充质干细胞的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011117871A1 (en) * | 2010-03-25 | 2011-09-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Photochemical electrode, construction and uses thereof |
-
2012
- 2012-11-05 CN CN201210437524.8A patent/CN102876630B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1330142A (zh) * | 2001-07-09 | 2002-01-09 | 中国人民解放军军事医学科学院野战输血研究所 | 人骨髓和脐带血间充质干细胞体外分离扩增和向神经细胞定向诱导的方法 |
CN1878860A (zh) * | 2003-11-11 | 2006-12-13 | 韩薰 | 分离和培养来自脐带血的间充质干细胞的方法 |
Non-Patent Citations (2)
Title |
---|
Human umbilical cord blood mesenchymal stem cell-derived extracellular matrix prohibits metastatic cancer cell MDA-MB-231 proliferation;Bo Sun et al;《Cancer Letters》;20101231;第296卷;178-185 * |
脐带血间充质干细胞研究中的若干问题;李翠等;《实用肝脏病杂志》;20101231;第13卷(第6期);470-473 * |
Also Published As
Publication number | Publication date |
---|---|
CN102876630A (zh) | 2013-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102876630B (zh) | 一种高效分离和扩增人脐带血间充质干细胞的方法 | |
Grisendi et al. | GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion | |
Han et al. | Optimization of human umbilical cord mesenchymal stem cell isolation and culture methods | |
Shetty et al. | Comparison of proliferative and multilineage differentiation potentials of cord matrix, cord blood, and bone marrow mesenchymal stem cells | |
Rebelatto et al. | Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue | |
AU2009343787B2 (en) | Isolation of human umbilical cord blood-derived mesenchymal stem cells | |
Sensebé et al. | Good manufacturing practices production of mesenchymal stem/stromal cells | |
CN102367435B (zh) | 人富血小板血浆的制备及在人间充质干细胞分离培养中的应用 | |
Suszynska et al. | The proper criteria for identification and sorting of very small embryonic-like stem cells, and some nomenclature issues | |
CN109234229B (zh) | 从胎盘血管分离间充质干细胞的方法和所用消化酶组合物 | |
WO2012068710A1 (zh) | 从微量人脂肪组织提取间充质干细胞及规模化培养的方法 | |
Eslaminejad et al. | Amniotic fluid stem cells and their application in cell-based tissue regeneration | |
Jeon et al. | Characterization of mouse clonal mesenchymal stem cell lines established by subfractionation culturing method | |
CN109628388B (zh) | 用消化酶组合物从胎盘血管分离间充质干细胞 | |
Ghasemzadeh et al. | Comparable osteogenic capacity of mesenchymal stem or stromal cells derived from human amnion membrane and bone marrow | |
RU2012107674A (ru) | Биотрансплантат для восстановления объема костной ткани при дегенеративных заболеваниях и травматических повреждениях костей и способ его получения | |
CN101486992B (zh) | 抑制破骨细胞生成的间充质干细胞及其制备方法与应用 | |
CN115011553A (zh) | 一种躯干神经嵴来源骨髓间充质干细胞的制备方法及用途 | |
CN102943064B (zh) | 一种自造血干细胞中高效分化扩增cd4阳性t细胞的方法 | |
CN112852727A (zh) | 一种人脐带来源Muse细胞的培养方法 | |
Deus et al. | Isolation and characterization of mesenchymal stem cells obtained from reusable and disposable bone marrow collection filters | |
Wuchter et al. | Mesenchymal Stromal Cells (MSC) | |
CN103789260A (zh) | 分离和扩增血液间充质干细胞的方法 | |
US10400211B1 (en) | Cell composition for tissue regeneration | |
Lee et al. | Minimal cube explant provides optimal isolation condition of mesenchymal stem cells from umbilical cord |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
DD01 | Delivery of document by public notice |
Addressee: Patent contact person of Shanghai Jinbao Bioengineering Co.,Ltd. Document name: Notification that Application Deemed not to be Proposed |
|
DD01 | Delivery of document by public notice | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200615 Address after: 201500 room 214 215, No.254, South trade road, Zhujing Town, Jinshan District, Shanghai Patentee after: Shanghai Golden Medical Insurance Bioengineering Co.,Ltd. Address before: 211189 No. 2, Southeast University Road, Jiangning Development Zone, Nanjing, Jiangsu Patentee before: SOUTHEAST University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230404 Address after: Room 403, No. 6, Lane 220, Sida Road, Hongkou District, Shanghai, 200081 Patentee after: Xia Liang Address before: Room 214 215, No. 254 Trade South Road, Zhujing Town, Jinshan District, Shanghai, 201500 Patentee before: Shanghai Golden Medical Insurance Bioengineering Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231208 Address after: Room J, 12th Floor, Building 1, No. 399, Zhongren Road, Jiading District, Shanghai, 200000 Patentee after: Shanghai Junze Leen Biotechnology Co.,Ltd. Address before: Room 403, No. 6, Lane 220, Sida Road, Hongkou District, Shanghai, 200081 Patentee before: Xia Liang |